Skip to main content

Opus Genetics, Inc. insider trading

IRDNASDAQ
$4.58+0.07 (+1.55%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+154.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • CGCam GallagherDirector3.4655%of company
  • GMGeorge MagrathChief Executive Officer2.4622%of company
  • BRBenjamin R. YerxaPresident0.8463%of company
  • RERobert E. GagnonChief Financial Officer0.6688%of company
  • AJAshwath JayagopalChief Scientific & Dev. Ofc.0.6121%of company
  • RJRichard J. RodgersDirector0.4123%of company
  • SASean AinsworthDirector0.3867%of company
  • JSJames S. J. ManusoDirector0.3814%of company
  • JKJoseph K. SchachleChief Operating Officer0.3503%of company
  • JBJean BennettDirector0.3113%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
IRDFoundation Fighting Blindness Retinal Degeneration FundDirectorOpen market sell$2.76M-14.7%$4.96$2.76MSep 30, 2026Oct 2, 2026
IRDRobert E. GagnonChief Financial OfficerOpen market sell$127K-4.8%$4.54$127KSep 3, 2026Sep 8, 2026
IRDBenjamin R. YerxaPresidentOpen market sell$22.1K-1.0%$2.97$22.1KJul 23, 2026Jul 27, 2026
IRDJoseph K. SchachleChief Operating OfficerOpen market sell$13.7K-1.6%$2.94$13.7KJul 23, 2026Jul 27, 2026
IRDGeorge MagrathChief Executive OfficerOpen market sell$27.9K-0.5%$2.95$27.9KJul 23, 2026Jul 27, 2026
IRDRobert E. GagnonChief Financial OfficerOpen market sell$22.9K-1.3%$2.95$22.9KJul 23, 2026Jul 27, 2026
IRDFoundation Fighting Blindness Retinal Degeneration FundDirectorOpen market sell$7.4M-31.0%$4.35$7.4MMay 18, 2026May 20, 2026
IRDBenjamin R. YerxaPresidentOpen market sell$39.1K-1.0%$5.24$39.1KApr 23, 2026Apr 27, 2026
IRDJoseph K. SchachleChief Operating OfficerOpen market sell$24.5K-1.6%$5.22$24.5KApr 23, 2026Apr 27, 2026
IRDRabourn Amy ZarembaHead of Fin. Quality AssuranceOpen market sell$8.53K-0.9%$5.20$8.53KApr 23, 2026Apr 27, 2026
IRDGeorge MagrathChief Executive OfficerOpen market sell$49.6K-0.5%$5.22$49.6KApr 23, 2026Apr 27, 2026
IRDAshwath JayagopalChief Scientific & Dev. Ofc.Open market sell$39.1K-1.5%$5.19$39.1KApr 23, 2026Apr 27, 2026
IRDRobert E. GagnonChief Financial OfficerOpen market sell$40.6K-1.3%$5.18$40.6KApr 23, 2026Apr 27, 2026
IRDJoseph K. SchachleChief Operating OfficerOpen market sell$19.5K-1.2%$5.25$19.5KMar 16, 2026Mar 18, 2026
IRDRabourn Amy ZarembaHead of Fin. Quality AssuranceOpen market sell$14.8K-1.5%$5.25$14.8KMar 16, 2026Mar 18, 2026
IRDGeorge MagrathChief Executive OfficerOpen market sell$127K-1.4%$5.21$127KMar 16, 2026Mar 18, 2026
IRDAshwath JayagopalChief Scientific & Dev. Ofc.Open market sell$19K-0.7%$5.12$19KMar 16, 2026Mar 18, 2026
IRDCam GallagherDirectorOpen market purchase$164K+2.2%$1.97$164KDec 29, 2025Dec 31, 2025
IRDCam GallagherDirectorOpen market purchase$160K+2.1%$1.98$160KDec 29, 2025Dec 31, 2025
IRDFoundation Fighting Blindness Retinal Degeneration FundDirectorOpen market sell$8.6M-42.1%$2.15$8.6MDec 9, 2025Dec 11, 2025
End of history · 20 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.